Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3774 3791 3796
This examiner grants 65% of resolved cases
Kyle W. Kretzer is an examiner in Tech Center 3700, specifically working in Art Unit 3774. The examiner has 176 resolved cases with an allowance rate of 64.2 percent. This rate provides a baseline for the probability of securing a grant during prosecution. The 176 resolved cases offer a reliable sample for evaluating the examiner's approach to patentability and the technical requirements of this art unit.
The data reveals a substantial interview lift of 43.1 percent. This 43.1 percent increase in the likelihood of allowance following an interview suggests that direct communication is a highly effective strategy for overcoming rejections. The median days to allowance is 1287, which measures the typical time from filing to patent issuance. Practitioners should consider the 1287-day median when planning their prosecution timeline. Given the 64.2 percent allowance rate and the significant interview lift, scheduling a meeting with the examiner is a key tactical recommendation for improving the chances of a successful outcome.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19018465 | ELECTRONIC DEVICE FOR MEASURING BIOMETRIC INFORMATION AND OPERATION METHOD THEREOF | Non-Final OA | Samsung Electronics Co., Ltd. |
| 18289608 | BIOLOGICAL INFORMATION ACQUISITION DEVICE, BIOLOGICAL INFORMATION ACQUISITION METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18147755 | SYSTEMS AND METHODS FOR ANALYTE MONITORING | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17556940 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18876013 | SYSTEMS AND METHODS FOR DETERMINING A FLUID RESPONSIVENESS PARAMETER AND A HEMODYNAMIC PARAMETER. | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18315858 | METHOD FOR PRODUCING AN ANALYTE SENSOR, AN ANALYTE SENSOR, AND A USE THEREOF | Non-Final OA | Roche Diabetes Care, Inc. |
| 18307071 | ANALYTE SENSOR SYSTEM AND A METHOD FOR ITS PRODUCING | Final Rejection | Roche Diabetes Care, Inc. |
| 18807831 | WEARABLE TRANSPLANTABLE TISSUE VIABILITY BIOSENSOR | Non-Final OA | The Regents of the University of California |
| 18264755 | ONE-TOUCH FINGERTIP SWEAT SENSOR AND PERSONALIZED DATA PROCESSING FOR RELIABLE PREDICTION OF BLOOD BIOMARKER CONCENTRATIONS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18693749 | BIOPSY NEEDLE ACCESSORY | Non-Final OA | The Johns Hopkins University |
| 19018361 | SYSTEM, APPARATUS, AND METHOD FOR EVALUATING VASCULAR ENDOTHELIAL FUNCTION | Non-Final OA | Murata Manufacturing Co., Ltd. |
| 18863758 | METHOD AND APPARATUS FOR DETERMINING ABNORMAL CARDIAC CONDITIONS NON-INVASIVELY | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 19055255 | HOME-BASED LABOR ONSET DETECTION SYSTEM AND METHOD | Non-Final OA | GE Precision Healthcare LLC |
| 17628598 | DETECTING APPARATUS AND DETECTING METHOD | Final Rejection | MAXELL, LTD. |
| 18911870 | HAEMODYNAMIC MONITOR WITH IMPROVED FILTERING | Non-Final OA | Masimo Corporation |
| 17416683 | TECHNIQUES FOR STIMULATION ARTEFACT ELIMINATION | Final Rejection | Cochlear Limited |
| 18636187 | OMNIPHOBIC PAPER BASED SMART BANDAGE DEVICES | Non-Final OA | Purdue Research Foundation |
| 17008101 | ADJUSTING SETTINGS TO DIFFERENT DEGREES OF AGGRESSIVENESS IN AN AUTOMATED INSULIN DELIVERY SYSTEM BASED ON QUALITY OF BLOOD GLUCOSE LEVEL CONTROL BY A USER | Final Rejection | Insulet Corporation |
| 19041712 | THYROID FUNCTION MONITORING METHOD ACCORDING TO MEDICATION, AND MONITORING SERVER AND USER TERMINAL PERFORMING THE SAME | Final Rejection | THYROSCOPE INC. |
| 18027391 | ABRASION PROTECTED MICRONEEDLE AND INDWELLING EAB SENSORS | Final Rejection | University Of Cincinnati |
| 18294564 | A DEVICE FOR NON-INVASIVE MONITORING | Non-Final OA | Teknologian tutkimuskeskus VTT Oy |
| 18210688 | Cloud Analysis System for Sport and Health | Final Rejection | Decentralized Biotechnology Intelligence Co., Ltd. |
| 18838408 | WEARABLE DEVICE AND METHOD FOR DETECTING AN ANALYTE IN TISSUE OF A HUMAN OR ANIMAL SUBJECT | Non-Final OA | DIAMONTECH AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy